Edwards Lifesciences Corp

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC EW

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

5,383,637

Value ($000)

458,955

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	458,955	0.1%	5,383,637	12/31/2025
2025 Q3	11/14/2025	434,318	0.1%	5,584,646	9/30/2025
2025 Q2	8/14/2025	115,467	0.0%	1,476,376	6/30/2025
2025 Q1	5/19/2025	491,673	0.1%	6,783,568	3/31/2025
2024 Q4	2/14/2025	482,621	0.1%	6,519,257	12/31/2024
2024 Q3	11/14/2024	396,322	0.1%	6,005,789	9/30/2024
2024 Q2	8/14/2024	549,095	0.2%	5,944,514	6/30/2024
2024 Q1	5/15/2024	420,412	0.1%	4,399,451	3/31/2024
2023 Q4	2/14/2024	304,425	0.1%	3,992,462	12/31/2023
2023 Q3	11/13/2023	267,560	0.1%	3,862,004	9/30/2023
2023 Q2	8/11/2023	326,356	0.2%	3,944,836	6/30/2023
2023 Q1	5/15/2023	326,356	0.2%	3,944,836	3/31/2023
2022 Q4	2/14/2023	280,472	0.1%	3,759,174	12/31/2022
2022 Q3	11/14/2022	304,655	0.2%	3,686,973	9/30/2022
2022 Q2	8/12/2022	436,575	0.2%	4,591,174	6/30/2022
2022 Q1	5/16/2022	571,476	0.2%	4,854,535	3/31/2022
2021 Q4	2/14/2022	854,978	0.3%	6,599,602	12/31/2021
2021 Q3	11/15/2021	498,287	0.2%	4,401,438	9/30/2021
2021 Q2	8/16/2021	446,155	0.2%	4,307,764	6/30/2021
2021 Q1	5/14/2021	304,052	0.1%	3,635,244	3/31/2021
2020 Q4	3/1/2021	415,100	0.2%	4,550,043	12/31/2020
2020 Q3	11/13/2020	459,591	0.2%	5,757,837	9/30/2020
2020 Q2	8/14/2020	361,698	0.2%	5,233,658	6/30/2020
2020 Q1	5/15/2020	325,093	0.2%	1,723,535	3/31/2020
2019 Q4	2/14/2020	372,079	0.2%	1,594,919	12/31/2019
2014 Q1	5/23/2014	33,922	0.0%	457,341	3/31/2014
2013 Q4	1/31/2014	27,860	0.0%	423,655	12/31/2013